Butedronic acid
- Level
- Commodity
- Parent
- 51182400
- Below
- 0
- Links · KBLI
- 8
Definition
UNSPSC 51182425This classification denotes a bone resorption inhibitor and biphosphonate, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 26PB1U68YF. European Medicines Agency schedules Butedronic acid in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06011MIG. Butedronic acid generally arises in the molecular formula C5H10O10P2. The term BUTEDRONIC ACID is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 3, no. 3, 1989, list 29.) As of Q4 2014, BUTEDRONIC ACID remains the US FDA Preferred Term for this commodity. Butedronic acid bears US NLM identifiers UMLS ID C2347239 and NCI Concept Code C72092. SMILES: P(=O)(O)(O)C(P(=O)(O)O)C(CC(=O)O)C(=O)O.
Same parent
Under 51182400 · 28Activities that produce or sell this
KBLI · 8Inherited from family 51180000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.